Quick Answer
DiaMedica Therapeutics Inc. reported Stockholders Equity of $56.11 million for fiscal year 2025.
DiaMedica Therapeutics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $56.11M | +37.8% |
| 2024 | $40.72M | -20.2% |
| 2023 | $51.06M | +60.4% |
| 2022 | $31.83M | -27.7% |
| 2021 | $44.02M | +69.2% |
| 2020 | $26.01M | +241.5% |
| 2019 | $7.62M | -55.3% |
| 2018 | $17.02M | +2030.8% |
| 2017 | $799.0K | -28.1% |
| 2016 | $1.11M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $51.62M | +7.6% | +90.0% |
| June 30, 2025 | $27.17M | -49.1% | -20.0% |
| March 31, 2025 | $33.95M | -26.7% | -16.6% |
| December 31, 2024 | $40.72M | -20.2% | -15.1% |
| September 30, 2024 | $47.96M | -13.8% | -10.2% |
| June 30, 2024 | $53.41M | -10.6% | +15.2% |
| March 31, 2024 | $46.35M | +71.5% | -9.2% |
| December 31, 2023 | $51.06M | +60.4% | -8.2% |
- DiaMedica Therapeutics Inc. showed an increase of +37.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, DiaMedica Therapeutics Inc.’s stockholders equity has grown by 4950.5% (from $1.11 million to $56.11 million).
- The most recent figure is from DiaMedica Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: